House generic Rx debate
Executive Summary
House Democrats' attempt to move generic drug reform legislation (HR 5311/5272) via a discharge petition meets with opposition from industry coalition. "We do not endorse pursuing a discharge petition," Blue Cross/ Blue Shield-organized Coalition for a Competitive Pharmaceutical Market says, "but we continue to urge the House to take immediate action to pass this critical legislation"...